Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Retour ŕ la liste des Items
Added by mollevi
Group name EquipePM
Item Type Note
Note

Thomas, Gaelle
Chardes, Thierry
Gaborit, Nadege
Mollevi, Caroline
Leconet, Wilhem
Robert, Bruno
Radosevic-Robin, Nina
Penault-Llorca, Frederique
Gongora, Celine
Colombo, Pierre-Emmanuel
Lazrek, Yassamine
Bras-Goncalves, Rui
Savina, Ariel
Azria, David
Bazin, Herve
Pelegrin, Andre
Larbouret, Christel
eng
Research Support, Non-U.S. Gov't
2014/09/13 06:00
Oncotarget. 2014 Aug 30;5(16):7138-48.
Date Added 2018/07/20 - 09:15:34
Date Modified 2018/07/20 - 09:15:34
Parent item HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés